MatOrtho® has achieved a significant milestone with the CE mark approval of its ReCerf® Hip Resurfacing Arthroplasty (HRA), enabling broader access to the world's first all-ceramic hip resurfacing implant across Europe. This innovative device is made from BIOLOX® delta ceramic, a material that eliminates the complications historically associated with metal-on-metal implants, such as metal ion release and tissue reactions. ReCerf® is the result of over two decades of research and development aimed at improving hip resurfacing outcomes with advanced materials that ensure long-term durability and biocompatibility.
Clinically introduced in 2018 and already in use by more than 1,600 patients globally, ReCerf® preserves more of the patient’s natural bone compared to total hip replacements and supports higher levels of physical activity—making it an ideal option for younger, active patients. The procedure maintains a surgical approach familiar to experienced resurfacing surgeons while offering the advantages of ceramic-on-ceramic articulation. Early clinical data shows strong patient-reported outcomes and a low revision rate, reinforcing confidence in the implant’s long-term performance.
The CE marking not only validates ReCerf®'s safety and performance under European standards but also marks an important step in expanding patient access to bone-conserving, metal-free hip resurfacing solutions. MatOrtho is committed to responsible adoption, with structured training programs for surgeons, strict patient selection criteria, and continued clinical monitoring. This regulatory achievement strengthens MatOrtho’s leadership in orthopaedic innovation and supports its mission to provide durable, high-performance solutions that restore joint function and support active lifestyles.
MedTech Soectrum's Summary
CE Mark Approval Expands Access: The CE mark for ReCerf® enables broader availability of the world’s first all-ceramic hip resurfacing implant across Europe, offering patients a safe, metal-free alternative with proven clinical performance.
Innovative, Bone-Conserving Design: Made from BIOLOX® delta ceramic, ReCerf® preserves more of the natural bone, reduces risk of metal-related complications, and supports active lifestyles—especially suited for younger patients.
Commitment to Safe Adoption: MatOrtho backs the rollout with structured surgeon training, patient selection protocols, and ongoing clinical monitoring, reinforcing its leadership in delivering responsible, high-performance orthopaedic solutions.
